|
[Related PubMed/MEDLINE]
Total Number of Papers: 35
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: ADRC |
| Long Form |
: Alzheimer's Disease Research Center |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies. |
AD, ADNC, AUC, DLB, LBD, NACC, PD, SNPs |
| 2 |
2020 |
Concordance of Lumipulse cerebrospinal fluid t-tau/Abeta42 ratio with amyloid PET status. |
Abeta42, AD, AUCs, CSF, PET, ROC |
| 3 |
2020 |
Development of Classification Models for the Prediction of Alzheimer's Disease Utilizing Circulating Sex Hormone Ratios. |
AD, LR, RP, WHAT-Cog |
| 4 |
2020 |
Informed Consent in Two Alzheimer's Disease Research Centers: Insights From Research Coordinators. |
AD, eConsent, IC |
| 5 |
2020 |
The U-ARE Protocol: A Pragmatic Approach to Decisional Capacity Assessment for Clinical Research. |
--- |
| 6 |
2019 |
Comparison of the Short Test of Mental Status and the Montreal Cognitive Assessment Across the Cognitive Spectrum. |
CN, MCI, MCSA, MoCA, STMS |
| 7 |
2019 |
Evaluation of Medicare Claims Data as a Tool to Identify Dementia. |
--- |
| 8 |
2019 |
Higher Body Mass Index Is Associated with Lower Cortical Amyloid-beta Burden in Cognitively Normal Individuals in Late-Life. |
AD, BMI |
| 9 |
2019 |
Retention of Alzheimer Disease Research Participants. |
--- |
| 10 |
2018 |
Application of the condensed protocol for the NIA-AA guidelines for the neuropathological assessment of Alzheimer's disease in an academic clinical practice. |
AD, CP, NIA-AA, UW |
| 11 |
2018 |
Minimizing the Sample Sizes of Clinical Trials on Preclinical and Early Symptomatic Stage of Alzheimer Disease. |
AD, WU |
| 12 |
2017 |
Attitudes toward clinical trials across the Alzheimer's disease spectrum. |
AD, CI, MCI, OR, UCLA |
| 13 |
2016 |
Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease. |
AD, CDR, CSF |
| 14 |
2016 |
Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels. |
Abeta42, AD, CDR, CSF, GDS, MCBP, MMSE, NPI-Q, p-tau181, PiB, POMS-SF, WU |
| 15 |
2015 |
Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results. |
AD |
| 16 |
2015 |
Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory. |
ADNI, BDNF, Met, Val |
| 17 |
2015 |
Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). |
ADAD, ADNI, DIAN, LOAD, NPC |
| 18 |
2014 |
Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation. |
ACE, AD, ADNI, CSF, IL-6R, MMP3 |
| 19 |
2012 |
11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder. |
Abeta42, AD, CSF, HIV |
| 20 |
2012 |
A model for the design and implementation of a participant recruitment registry for clinical studies of older adults. |
--- |
| 21 |
2012 |
Genome-wide association study of Alzheimer's disease with psychotic symptoms. |
AD, AD-P, APOE, GERAD1, GWASs, NIA-LOAD, SNPs |
| 22 |
2011 |
An interdisciplinary outreach model of African American recruitment for Alzheimer's disease research. |
--- |
| 23 |
2011 |
Importance of symptomatic cerebral infarcts on cognitive performance in patients with Alzheimer's disease. |
AD |
| 24 |
2010 |
Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: the essential role of the neuropathology core. |
ADNI, NACC, NPC |
| 25 |
2009 |
Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA). |
AD, BLSA, NIA |
| 26 |
2009 |
Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome. |
ADPR, AED, EEG |
| 27 |
2006 |
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. |
FTLD, PGRN |
| 28 |
2006 |
On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease. |
AD |
| 29 |
2004 |
Progressive posterior cortical dysfunction: a clinicopathologic series. |
AD, CDR, DAT, PPCD |
| 30 |
2003 |
Testing correlation of cognitive decline at adjacent stages of dementia. |
--- |
| 31 |
2001 |
Using "good and bad surprises" to guide improvement efforts: insights from a memory assessment clinic. |
--- |
| 32 |
1998 |
Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. |
AD, APOE, UCSD |
| 33 |
1998 |
Differentiating drivers with dementia of the Alzheimer type from healthy older persons with a Traffic Sign Naming test. |
DAT |
| 34 |
1998 |
Validity of the Quality of Well-Being Scale for patients with Alzheimer's disease. |
QWB |
| 35 |
1995 |
Geographically overlapping Alzheimer's disease registries: comparisons and implications. |
ADPR |
|
A Search Service for Abbreviation / Long Form
